SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Trading risks for markets: The international harmonisation of pharmaceuticals regulation
0 references·5 citing·28 second hop
Trading risks for markets: The international harmonisation of pharmaceuticals regulation (2001)Trading risks for markets: The internatio…Documenting the financialisation of the pharmaceutical industry (2020)Documenting the financialisat…Not Quite the Same (2017)Not Quite the SameNGOs, Controversies, and “Opening Up” of Regulatory Governance of Science in India (2017)NGOs, Controversies, and “Ope…Governing lipitor and lipstick: Capacity, sequencing, and power in international pharmaceutical and cosmetics regulation (2010)Governing lipitor and lipstic…Pharmaceuticals in Australia: developments in regulation and governance (2003)Pharmaceuticals in Australia:…THE PHARMACEUTICAL BENEFITS SCHEME (1976)Liberalism, Neoliberalism, and Urban Governance: A State–Theoretical Perspective (2002)The Future of the Capitalist State. (2002)Methods for the comparative evaluation of pharmaceuticals. (2005)The Future of the Capitalist State (2005)What governs governance, and how does it evolve? The sociology of governance‐in‐action (2008)Diplomacy and domestic politics: the logic of two-level games (1988)Path dependence in historical sociology (2000)Politics in Time (2004)Putting the EU in its place: policy strategies and the global regulatory context (2015)Deciding to Defer: The Importance of Fairness in Resolving Transnational Jurisdictional Conflicts (2016)Power transitions and the rise of the regulatory state: Global market governance in flux (2021)The Logic of Comparative Social Inquiry. (1971)Case Selection Techniques in Case Study Research (2008)Lobbying and Policy Change (2009)Theorizing Regulatory Intermediaries (2017)The European regulation of corporate social responsibility: The role of beneficiaries' intermediaries (2019)Coordinating monetary policy and macroprudential policy: Bureaucratic politics, regulatory intermediary, and bank lobbying (2021)The rise of the regulatory state in Europe (1994)“Opening Up” and “Closing Down” (2007)Economic and Political Weekly (2017)Constructing ‘Responsive’ Publics: The Politics of Public Engagement under India’s ‘Decade of Innovation’ Framework (2023)New Evidence and Perspectives on Mergers (2001)Financialization and the World Economy (2005)Making sense of financialization (2014)21st Century Capitalism and Innovation for Health (2021)Patents over patients? Exploring the variegated financialization of the pharmaceuticals industry through mergers and acquisitions (2022)High drug prices are not justified by industry’s spending on research and development (2023)
this work references cited by second hop

References

No references inside the corpus for this window.

Cited by

  • 2003Pharmaceuticals in Australia: developments in regulation and governance77 cited
  • 2020Documenting the financialisation of the pharmaceutical industry44 cited
  • 2010Governing lipitor and lipstick: Capacity, sequencing, and power in international pharmaceutical and cosmetics regulation44 cited
  • 2017Not Quite the Same27 cited
  • 2017NGOs, Controversies, and “Opening Up” of Regulatory Governance of Science in India7 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work